Danaher

DANAHER CORP

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.

August,25,,2019,Pleasanton, - ,Ca, - ,Usa,-,Close

News

Markets

Media

Trading Ideas

APLD

ASTS

CRWV

CTRA

DOCU

WDAY

Stay away from Workday, Jim Cramer says. &#34;I&#39;m worried. There&#39;s a lot of companies coming for Workday, and I don&#39;t like that.&#34;

Jim Cramer &#39;Worried&#39; About Workday, Calls Applied Digital &#39;A Good Spec&#39;

West,Bangal,,India,-,April,20,,2022,:,Danaher,Corporation

Analyst Color

Earnings

Large Cap

Guidance

Health Care

Price Target

Analyst Ratings

General

Danaher beat Q1 forecasts with $5.74 billion in sales and $1.88 EPS. Analyst sees upside ahead as bioprocess growth and CDMO demand improve.

Analyst Sees Opportunity In Danaher Stock As Sentiment Improves

Danaher beat Q1 2025 estimates and analysts noted resilience despite macro pressures and China-related headwinds.

Danaher Pricing Strategy Key To Navigating Tariff Challenges: Analyst

Danaher Corp

DEUTSCHE EUROSHOP UNS/ADR by Deutsche Euroshop AG

Deutsche EuroShop AG

Dividends

Press Releases

Danaher Announces Quarterly Dividend

Danaher to Present at Bank of America Securities Healthcare Conference

Aldevron and Integrated DNA Technologies Manufacture World's First mRNA-based Personalized CRISPR Therapy

Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine

SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations

SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement

Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations

Danaher Schedules Second Quarter 2025 Earnings Conference Call

Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences

Danaher Appoints Martin Stumpe as Chief Technology and AI Officer

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Danaher

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell